Vera Therapeutics Inc (VERA) — Strategic Asset Allocation Index
Vera Therapeutics Inc (VERA) has a Strategic Asset Allocation Index of 0.0% as of September 2023. Strategic assets (PP&E of $- plus long-term investments of $13.00K) total $13.00K, measured against net assets of $123.71 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Vera Therapeutics Inc Strategic Asset Allocation Index (2021–2022)
This chart shows how Vera Therapeutics Inc's Strategic Asset Allocation Index has evolved across 2 annual periods from 2021 to 2022. As of September 2023, the index stands at 0.0%, representing strategic assets of $13.00K against net assets of $123.71 Million USD. Explore Vera Therapeutics Inc (VERA) cash flow conversion to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for Vera Therapeutics Inc (2021–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Vera Therapeutics Inc from 2021 to 2022, covering 2 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see Vera Therapeutics Inc stock valuation.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 0.1% | $109.00K | $51.00K | $58.00K | $76.91 Million | ▼ -1.1 pp |
| 2021 | 1.2% | $867.00K | $- | $867.00K | $69.59 Million | — |